XML 60 R29.htm IDEA: XBRL DOCUMENT v3.20.1
ORGANIZATION AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables)
12 Months Ended
Dec. 31, 2019
Revenue from External Customer [Line Items]  
Schedule of Cash and Cash Equivalents [Table Text Block]
The following table provides a reconciliation of cash, cash equivalents, and restricted cash reported within the Company's consolidated balance sheets to the total amount presented in the consolidated statement of cash flows (in thousands):

 
December 31, 2019
December 31, 2018

Cash and cash equivalents at beginning of period
$
21,845

$
37,682

Current restricted cash at beginning of period
1,514

1,514

Long-term restricted cash at beginning of period
7,225

7,565

Cash, cash equivalents, and restricted cash at beginning of period
$
30,584

$
46,761

 
 
 
Cash and cash equivalents at end of period
$
24,762

$
21,845

Current restricted cash at end of period
943

1,514

Long-term restricted cash at end of period
5,295

7,225

Cash, cash equivalents, and restricted cash at end of period
$
31,000

$
30,584

Revenue from External Customers by Products and Services [Table Text Block]
Our sales mix for the years ended December 31, was as follows (in millions, except percentages):
 
2019
 
Percentage
 
2018
 
Percentage
Consolidated product sales
$
154.6

 
98.0
%
 
$
170.2

 
98.0
%
Consolidated pack sales and associate fees(a)
2.3

 
1.5
%
 
2.5

 
1.5
%
Consolidated other
0.8

 
0.5
%
 
0.9

 
0.5
%
Total consolidated net sales
$
157.7

 
100.0
%
 
$
173.6

 
100.0
%
Estimated useful lives of fixed assets
The estimated useful lives of fixed assets are as follows:

 
Estimated useful life
Office furniture and equipment
5 to 7 years
Computer hardware and software
3 to 5 years
Automobiles
3 to 5 years
Leasehold improvements (1)
2 to 10 years
(1) The Company amortizes leasehold improvements over the shorter of the useful estimated life of the leased asset or the lease term.
Loyalty deferred revenue

Loyalty program
(in thousands)

Loyalty deferred revenue as of January 1, 2018
$
6,406

Loyalty points forfeited or expired
(4,332
)
Loyalty points used
(11,398
)
Loyalty points vested
12,469

Loyalty points unvested
1,086

Loyalty deferred revenue as of December 31, 2018
$
4,231


Loyalty deferred revenue as of January 1, 2019
$
4,231

Loyalty points forfeited or expired
(4,348
)
Loyalty points used
(9,127
)
Loyalty points vested
11,320

Loyalty points unvested
1,051

Loyalty deferred revenue as of December 31, 2019
$
3,127

Sales return reserve
For the years ended December 31, 2019 and December 31, 2018, our sales return reserve consisted of the following (in thousands):

Sales reserve as of January 1, 2018
$
117

Provision related to sales made in current period
1,198

Adjustment related to sales made in prior periods
(10
)
Actual returns or credits related to current period
(1,125
)
Actual returns or credits related to prior periods
(104
)
Sales reserve as of December 31, 2018
$
76

 
 
Sales reserve as of January 1, 2019
$
76

Provision related to sales made in current period
1,037

Adjustment related to sales made in prior periods
31

Actual returns or credits related to current period
(973
)
Actual returns or credits related to prior periods
(103
)
Sales reserve as of December 31, 2019
$
68

Concentration risk
Revenue from these products were as follows for the years ended December 31, 2019 and 2018 (in thousands, except percentages):
 
2019

2018
 
Sales by
product

% of total
net sales

Sales by
product

% of total
net sales
Ambrotose Life® 
$
34,975


22.2
%

$
18,824


10.9
%
Advanced Ambrotose®
22,390


14.2
%

44,054


25.4
%
TruHealth
16,193


10.3
%

17,537


10.1
%
Manapol® Powder
8,793


5.6
%

8,636


5.0
%
GI-Pro Balance
6,559


4.2
%

7,187


4.2
%
Total
$
88,910


56.5
%

$
96,238


55.6
%